Greenleaf Trust’s Brookfield BN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$430K Sell
10,104
-557
-5% -$24.9K ﹤0.01% 558
2026
Q1
$431K Buy
10,661
+1,570
+17% +$69.6K ﹤0.01% 526
2025
Q4
$417K Sell
9,091
-2
-0% -$91 ﹤0.01% 556
2025
Q3
$416K Buy
9,093
+313
+4% +$13.9K ﹤0.01% 545
2025
Q2
$362K Buy
8,780
+183
+2% +$6.78K ﹤0.01% 572
2025
Q1
$300K Sell
8,597
-753
-8% -$28.5K ﹤0.01% 644
2024
Q4
$358K Hold
9,350
﹤0.01% 596
2024
Q3
$331K Buy
+9,350
New +$295K ﹤0.01% 631
2022
Q4
Sell
-14,599
Closed -$322K 749
2022
Q3
$322K Sell
14,599
-22
-0.2% -$570 ﹤0.01% 515
2022
Q2
$350K Buy
14,621
+22
+0.2% +$588 0.01% 503
2022
Q1
$445K Buy
+14,599
New +$436K 0.01% 458

Other funds holding BN

Greenleaf Trust's BN Position: Q2 2026 in Review

Greenleaf Trust reduced its Brookfield (BN) stake by 5.2% in Q2 2026, selling an estimated $24.9K and leaving 10,104 shares worth $430K. The position accounts for ﹤0.01% of the portfolio, ranked #558.

Greenleaf Trust first reported a position in BN in Q1 2022 and has held it in 11 quarters since. The position peaked at $445K in Q1 2022. 941 funds tracked by Wall St. Rank hold BN as of Q2 2026.

  • Greenleaf Trust held 10,104 shares of Brookfield worth $430K as of Q2 2026.
  • Greenleaf Trust sold 557 Brookfield shares in Q2 2026, an estimated $24.9K.
  • Brookfield made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #558 holding.
  • Greenleaf Trust first reported a position in Brookfield in Q1 2022 and has held it in 11 quarters since.
  • Greenleaf Trust's Brookfield position peaked at $445K in Q1 2022.
  • 941 funds tracked by Wall St. Rank held Brookfield as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.